TearLab Corporation (NASDAQ:TEAR)
Industry: Healthcare

OFF LIST - 1110 consecutive market days: OFF LIST as of 01/06/2012 Through 11/14/2016

TearLab Corporation operates as an in-vitro diagnostic company in the United States and internationally. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease; and enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, a single-use microfluidic microchip; TearLab pen, a hand-held device that interfaces with the TearLab disposable; and TearLab reader, a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corporation was founded in 1996 and is headquartered in San Diego, California.

Current Quote*
Last: $0.100
Change: 0.000
Book: $Unk
Volume: 10,604

As Of: 11/16 15:55 ET
*Quotes delayed by 20min.

Graphs for TEAR

3 Month Graph

6 Month Graph

1 Year Graph